The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Bayer
University of Florida
Seagen Inc.
City of Hope Medical Center
Merck Sharp & Dohme LLC
TransThera Sciences (Nanjing), Inc.
Instituto do Cancer do Estado de São Paulo
Elevation Oncology
Universidade Federal de Pernambuco
TransThera Sciences (Nanjing), Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MacroGenics
Abramson Cancer Center at Penn Medicine
Montefiore Medical Center
City of Hope Medical Center
Duke University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
NYU Langone Health
Case Comprehensive Cancer Center